Literature DB >> 2139300

Pharmacological profile of HWA-131, a novel antiinflammatory agent with immunomodulating properties.

R R Bartlett1, R Schleyerbach, K U Weithmann, W Thorwart.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2139300     DOI： 10.1007/bf01964725

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  5 in total

1.  Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw.

Authors:  D M Siegel; S N Giri; R M Scheinholtz; L W Schwartz
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

2.  Effects of antiarthritic compounds on type II collagen-induced arthritis in rats.

Authors:  A W Probert; D J Schrier; R B Gilbertsen
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-05

3.  The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.

Authors:  S Popovic; R R Bartlett
Journal:  Agents Actions       Date:  1987-08

4.  Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.

Authors:  R R Bartlett; R Schleyerbach
Journal:  Int J Immunopharmacol       Date:  1985

5.  Biochemical and pharmacological effects of dipyrone and its metabolites in model systems related to arachidonic acid cascade.

Authors:  K U Weithmann; H G Alpermann
Journal:  Arzneimittelforschung       Date:  1985
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.